More Biotron Limited news
Biotron LimitedASX: BIT

Interim HCV genotype 3 data from BIT225-008 study

Feb 11, 2016 at 1:19 AM EST · Issued by Biotron Limited

Filed with ASX · Feb 11, 2016 at 1:19 AM EST · 3 pages · English

On 6ix: 6ix.com/news/interim-hcv-genotype-3-data-from-bit225-008-study

Biotron Limited on 6ix

Earlier from Biotron

  • Annual Report to ShareholdersFeb 10, 2016

Later from Biotron

  • Biotron compounds tested for activity against Zika virusFeb 16, 2016
  • BIT225 May have a broader role in limiting HIV-1 infectionFeb 18, 2016
  • Phase 2 Hepatitis C Trial SuccessMar 17, 2016
  • Trading haltMar 30, 2016
  • $1.5 Million R&D Tax RebateApr 20, 2016
All Biotron news releases↗

Follow Biotron into a list and get an email when it puts out news.

Follow Biotron
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer